Arimoclomol maleate

CAS No. 289893-26-1

Arimoclomol maleate( BRX-220 )

Catalog No. M24208 CAS No. 289893-26-1

Arimoclomol maleate (BRX-220) is a heat shock protein (HSP) co-inducer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 65 In Stock
25MG 132 In Stock
50MG 222 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Arimoclomol maleate
  • Note
    Research use only, not for human use.
  • Brief Description
    Arimoclomol maleate (BRX-220) is a heat shock protein (HSP) co-inducer.
  • Description
    Arimoclomol maleate (BRX-220) is a heat shock protein (HSP) co-inducer.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Male Wistar rats weighing 240 to 270 g Dosage:20 mg/kg Administration:Administered intragastrically, for 5 days Result:Had a protective effect against CCK-induced acute pancreatitis.
  • Synonyms
    BRX-220
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    HSP
  • Recptor
    HSP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    289893-26-1
  • Formula Weight
    429.85
  • Molecular Formula
    C18H24ClN3O7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:250 mg/mL (581.60 mM; Need ultrasonic)
  • SMILES
    Cl/C(C1=C[N+]([O-])=CC=C1)=N\OC[C@H](O)CN2CCCCC2.OC(/C=C\C(O)=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rakonczay Z Jr, et al. Nontoxic heat shock protein coinducer BRX-220 protects against acute pancreatitis in rats. Free Radic Biol Med. 2002 Jun 15;32(12):1283-92.
molnova catalog
related products
  • Alvespimycin hydroch...

    A potent, orally bioavailable Hsp90 inhibitor with binding EC50 of 62 nM.

  • KUNG29

    A potent, selective Grp94 inhibitor with Kd of 0.2 uM.

  • Periplocin

    Periplocin has anti-cancer effects on lung cancer cells, induces apoptosis and inhibits growth of cancer cells by the beta-catenin/Tcf signaling pathway.